期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 231, 期 1-2, 页码 86-91出版社
ELSEVIER
DOI: 10.1016/j.jneuroim.2010.09.012
关键词
Limbic encephalitis; Anti-NMDA-receptor encephalitis; Anti-glutamate receptor (type NMDA) antibody; Anti-glutamate receptor (type AMPA) antibody; Anti-VGKC antibody; Recombinant immunofluorescence assay
Anti-NMDA-receptor encephalitis is a severe, treatable and potentially reversible disorder presenting with memory deficits, psychiatric symptoms and seizures. Initially described in young patients with ovarian teratoma, the disease is meanwhile increasingly recognized also in women without tumours, in men and in children. The presence of anti-glutamate receptor (type NMDA) autoantibodies in serum or cerebrospinal fluid is specific for this novel and widely underdiagnosed disorder. Early recognition is crucial since prognosis largely depends on adequate immunotherapy and, in paraneoplastic cases, complete tumour removal. Indirect immunofluorescence using NMDA-type glutamate receptors recombinantly expressed in human cells is a highly competent method for diagnosing anti-NMDA-receptor encephalitis. (C) 2010 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据